Switch theme
Sign up to access all valuation multiples
Ubcare Co Ltd is a South Korea-based company that engages in the provision of healthcare solutions. Its business divisions are: EMR solutions, distribution, pharmaceutical data, and manufacturing.
1994
338
Last FY Revenue $139M
Last FY EBITDA $7.3M
$134M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Ubcare Co achieved revenue of $139M and an EBITDA of $7.3M.
Ubcare Co expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Ubcare Co valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $139M | XXX | XXX | XXX |
| Gross Profit | XXX | $69.6M | XXX | XXX | XXX |
| Gross Margin | XXX | 50% | XXX | XXX | XXX |
| EBITDA | XXX | $7.3M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 5% | XXX | XXX | XXX |
| EBIT | XXX | $3.8M | XXX | XXX | XXX |
| EBIT Margin | XXX | 3% | XXX | XXX | XXX |
| Net Profit | XXX | -$1.2M | XXX | XXX | XXX |
| Net Margin | XXX | -1% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 31, 2025, Ubcare Co's stock price is KRW 3830 (or $3).
Ubcare Co has current market cap of KRW 194B (or $141M), and EV of KRW 183B (or $134M).
See Ubcare Co trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $134M | $141M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 31, 2025, Ubcare Co has market cap of $141M and EV of $134M.
Ubcare Co's trades at 1.0x EV/Revenue multiple, and 18.2x EV/EBITDA.
Equity research analysts estimate Ubcare Co's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Ubcare Co's P/E ratio is not available.
See valuation multiples for Ubcare Co and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $141M | XXX | $141M | XXX | XXX | XXX |
| EV (current) | $134M | XXX | $134M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 1.0x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 18.2x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 35.5x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -122.5x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -46.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialUbcare Co's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.2M for the same period.
Ubcare Co's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Ubcare Co's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Ubcare Co and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 5% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 25% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 1% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 47% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
| Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
| Mach7 Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Ubcare Co acquired XXX companies to date.
Last acquisition by Ubcare Co was XXXXXXXX, XXXXX XXXXX XXXXXX . Ubcare Co acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Ubcare Co founded? | Ubcare Co was founded in 1994. |
| Where is Ubcare Co headquartered? | Ubcare Co is headquartered in South Korea. |
| How many employees does Ubcare Co have? | As of today, Ubcare Co has 338 employees. |
| Is Ubcare Co publicy listed? | Yes, Ubcare Co is a public company listed on KRX. |
| What is the stock symbol of Ubcare Co? | Ubcare Co trades under 032620 ticker. |
| When did Ubcare Co go public? | Ubcare Co went public in 1997. |
| Who are competitors of Ubcare Co? | Similar companies to Ubcare Co include e.g. Alcidion Group, CurveBeam AI, Doctor Care Anywhere, Echo IQ. |
| What is the current market cap of Ubcare Co? | Ubcare Co's current market cap is $141M |
| Is Ubcare Co profitable? | Yes, Ubcare Co is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
